Pandey N, Vinod P
iScience. 2022; 25(7):104543.
PMID: 35747391
PMC: 9209725.
DOI: 10.1016/j.isci.2022.104543.
Whitaker R, Cook J
Biomolecules. 2021; 11(10).
PMID: 34680077
PMC: 8533283.
DOI: 10.3390/biom11101444.
Hou W, Hao Y, Yang W, Tian T, Fang P, Du Y
Drug Des Devel Ther. 2021; 15:3845-3862.
PMID: 34526765
PMC: 8436178.
DOI: 10.2147/DDDT.S308713.
Sancho M, Leiva D, Lucendo E, Orzaez M
FEBS J. 2021; 289(20):6209-6234.
PMID: 34310025
PMC: 9787394.
DOI: 10.1111/febs.16136.
Omori T, Tazawa H, Yamakawa Y, Osaki S, Hasei J, Sugiu K
PLoS One. 2021; 16(4):e0250643.
PMID: 33886686
PMC: 8061981.
DOI: 10.1371/journal.pone.0250643.
MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation.
Whitaker R, Placzek W
Cell Death Dis. 2020; 11(2):156.
PMID: 32111816
PMC: 7048787.
DOI: 10.1038/s41419-020-2351-1.
Ferulic Acid Induces Apoptosis of HeLa and Caski Cervical Carcinoma Cells by Down-Regulating the Phosphatidylinositol 3-Kinase (PI3K)/Akt Signaling Pathway.
Luo L, Zhu S, Tong Y, Peng S
Med Sci Monit. 2020; 26:e920095.
PMID: 31983729
PMC: 7003662.
DOI: 10.12659/MSM.920095.
Jieduan-Niwan Formula Reduces Liver Apoptosis in a Rat Model of Acute-on-Chronic Liver Failure by Regulating the E2F1-Mediated Intrinsic Apoptosis Pathway.
Yang W, Hao Y, Hou W, Fang X, Fang P, Jiang T
Evid Based Complement Alternat Med. 2019; 2019:8108503.
PMID: 31827563
PMC: 6885299.
DOI: 10.1155/2019/8108503.
Cancer Metabolism and the Evasion of Apoptotic Cell Death.
Sharma A, Boise L, Shanmugam M
Cancers (Basel). 2019; 11(8).
PMID: 31405035
PMC: 6721599.
DOI: 10.3390/cancers11081144.
Activation of E2F-dependent transcription by the mouse cytomegalovirus M117 protein affects the viral host range.
Ostermann E, Loroch S, Qian Z, Sickmann A, Wiebusch L, Brune W
PLoS Pathog. 2018; 14(12):e1007481.
PMID: 30532172
PMC: 6301716.
DOI: 10.1371/journal.ppat.1007481.
Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.
Aubrecht T, Faden A, Sabirzhanov B, Glaser E, Roelofs B, Polster B
Cell Death Dis. 2018; 9(11):1121.
PMID: 30401820
PMC: 6219504.
DOI: 10.1038/s41419-018-1156-y.
The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells.
Zocchi L, Wu S, Wu J, Hayama K, Benavente C
Oncotarget. 2018; 9(34):23505-23518.
PMID: 29805751
PMC: 5955096.
DOI: 10.18632/oncotarget.25239.
Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.
Yamakawa Y, Tazawa H, Hasei J, Osaki S, Omori T, Sugiu K
Cancer Sci. 2017; 108(9):1870-1880.
PMID: 28685948
PMC: 5581539.
DOI: 10.1111/cas.13316.
PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics.
Cui J, Placzek W
Cell Death Differ. 2016; 23(10):1681-90.
PMID: 27367564
PMC: 5041196.
DOI: 10.1038/cdd.2016.60.
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.
Chen J
Cold Spring Harb Perspect Med. 2016; 6(3):a026104.
PMID: 26931810
PMC: 4772082.
DOI: 10.1101/cshperspect.a026104.
The downregulation of the RNA-binding protein Staufen2 in response to DNA damage promotes apoptosis.
Zhang X, Trepanier V, Beaujois R, Viranaicken W, Drobetsky E, DesGroseillers L
Nucleic Acids Res. 2016; 44(8):3695-712.
PMID: 26843428
PMC: 4856980.
DOI: 10.1093/nar/gkw057.
E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.
Muthusamy S, Hong K, Dassanayaka S, Hamid T, Jones S
J Biol Chem. 2015; 290(52):31013-24.
PMID: 26527687
PMC: 4692227.
DOI: 10.1074/jbc.M115.677534.
E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program.
Jiang X, Nevins J, Shats I, Chi J
PLoS One. 2015; 10(6):e0127951.
PMID: 26039627
PMC: 4454684.
DOI: 10.1371/journal.pone.0127951.
The CDKN1B-RB1-E2F1 pathway protects mouse spermatogonial stem cells from genomic damage.
Tanaka T, Kanatsu-Shinohara M, Shinohara T
J Reprod Dev. 2015; 61(4):305-16.
PMID: 25959802
PMC: 4547988.
DOI: 10.1262/jrd.2015-027.
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.
Santer F, Erb H, Oh S, Handle F, Feiersinger G, Luef B
Oncotarget. 2015; 6(8):6105-22.
PMID: 25749045
PMC: 4467425.
DOI: 10.18632/oncotarget.3368.